Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury

Critical Care, Sep 2017

Inflammation plays an important role in the initiation and progression of acute kidney injury (AKI). However, evidence regarding the prognostic effect of the platelet-to-lymphocyte ratio (PLR), a novel systemic inflammation marker, among patients with AKI is scarce. In this study, we investigated the value of the PLR in predicting the outcomes of critically ill patients with AKI. Patient data were extracted from the Multiparameter Intelligent Monitoring in Intensive Care Database III version 1.3. PLR cutoff values were determined using smooth curve fitting or quintiles and were used to categorize the subjects into groups. The clinical outcomes were 30-day and 90-day mortality in the intensive care unit (ICU). Cox proportional hazards models were used to evaluate the association between the PLR and survival. A total of 10,859 ICU patients with AKI were enrolled. A total of 2277 thirty-day and 3112 ninety-day deaths occurred. A U-shaped relationship was observed between the PLR and both 90-day and 30-day mortality, with the lowest risk being at values ranging from 90 to 311. The adjusted HR (95% CI) values for 90-day mortality given risk values < 90 and > 311 were 1.25 (1.12–1.39) and 1.19 (1.08–1.31), respectively. Similar trends were observed for 30-day mortality or when quintiles were used to group patients according to the PLR. Statistically significant interactions were found between the PLR and both age and heart rate. Younger patients (aged < 65 years) and those with more rapid heart rates (≥89.4 beats per minute) tended to have poorer prognoses only when the PLR was < 90, whereas older patients (aged ≥ 65 years) and those with slower heart rates (<89.4 beats per minute) had higher risk only when the PLR was > 311 (P < 0.001 for age and P < 0.001 for heart rate). The preoperative PLR was associated in a U-shaped pattern with survival among patients with AKI. The PLR appears to be a novel, independent prognostic marker of outcomes in critically ill patients with AKI.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://ccforum.biomedcentral.com/track/pdf/10.1186/s13054-017-1821-z?site=ccforum.biomedcentral.com

Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury

Zheng et al. Critical Care Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury Chen-Fei Zheng 3 Wen-Yue Liu 2 Fang-Fang Zeng 1 7 Ming-Hua Zheng 6 Hong-Ying Shi 5 Ying Zhou 4 Jing-Ye Pan 0 0 Department of Intensive Care, The First Affiliated Hospital of Wenzhou Medical University , Wenzhou 325000 , China 1 Department of Epidemiology, School of Basic Medical Sciences, Jinan University , Guangzhou 510632 , China 2 School of the First Clinical Medical Sciences, Wenzhou Medical University , Wenzhou 325000 , China 3 Department of Nephrology, the First Affiliated Hospital of Wenzhou Medical University , Wenzhou 325000 , China 4 Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health and Guangdong Province , Guangzhou 510000 , China 5 Department of Preventive Medicine, Wenzhou Medical University , Wenzhou 325000 , China 6 Department of Infection and Liver Diseases, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University , Wenzhou 325000 , China 7 Guangdong Provincial Key Laboratory of Food , Nutrition, and Health , School of Public Health, Sun Yat-sen University , Guangzhou 510000 , China Background: Inflammation plays an important role in the initiation and progression of acute kidney injury (AKI). However, evidence regarding the prognostic effect of the platelet-to-lymphocyte ratio (PLR), a novel systemic inflammation marker, among patients with AKI is scarce. In this study, we investigated the value of the PLR in predicting the outcomes of critically ill patients with AKI. Methods: Patient data were extracted from the Multiparameter Intelligent Monitoring in Intensive Care Database III version 1.3. PLR cutoff values were determined using smooth curve fitting or quintiles and were used to categorize the subjects into groups. The clinical outcomes were 30-day and 90-day mortality in the intensive care unit (ICU). Cox proportional hazards models were used to evaluate the association between the PLR and survival. Results: A total of 10,859 ICU patients with AKI were enrolled. A total of 2277 thirty-day and 3112 ninety-day deaths occurred. A U-shaped relationship was observed between the PLR and both 90-day and 30-day mortality, with the lowest risk being at values ranging from 90 to 311. The adjusted HR (95% CI) values for 90-day mortality given risk values < 90 and > 311 were 1.25 (1.12-1.39) and 1.19 (1.08-1.31), respectively. Similar trends were observed for 30-day mortality or when quintiles were used to group patients according to the PLR. Statistically significant interactions were found between the PLR and both age and heart rate. Younger patients (aged < 65 years) and those with more rapid heart rates (≥89.4 beats per minute) tended to have poorer prognoses only when the PLR was < 90, whereas older patients (aged ≥ 65 years) and those with slower heart rates (<89.4 beats per minute) had higher risk only when the PLR was > 311 (P < 0.001 for age and P < 0.001 for heart rate). Conclusions: The preoperative PLR was associated in a U-shaped pattern with survival among patients with AKI. The PLR appears to be a novel, independent prognostic marker of outcomes in critically ill patients with AKI. Platelet-to-lymphocyte ratio; Acute kidney injury; Prognosis; Intensive care unit Background More than 5 million patients are admitted to intensive care units (ICUs) each year in America [ 1, 2 ], and 6–24% of these patients have acute kidney injury (AKI) [3]. In the presence of AKI, patient mortality increases to as high as 60–70%, especially within 1 year after ICU admission [ 4–6 ]. Considering the high incidence of AKI in the ICU and its poor prognosis, an increasing number of observational studies over the past 2 decades have been devoted to identifying the clinical predictors of mortality in AKI. Systemic inflammation is an integral part of disease progression in critical illness and is commonly associated with sepsis, leading to an increased risk of mortality [ 7, 8 ]. Inflammation plays an important role in the initiation and progression of AKI [ 9–11 ], and morphological and/or functional changes in vascular endothelial cells and/or in the tubular epithelium are observed in patients with AKI. Leukocytes, including lymphocytes, infiltrate the injured kidneys and the entire body via the circulatory system and induce the generation of inflammatory mediators such as cytokines and chemokines, which damage the kidney and other organs [12]. The antithrombotic effects of platelets can evolve into atherogenesis via the secretion of proinflammatory cytokines [ 13 ], whereas the binding of platelets to endothelial cells can trigger leukocyte transmigration and adhesion, especially in the presence of shear stress [ 14 ]. The platelet-tolymphocyte ratio (PLR) has been introduced as a potential marker of inflammation in cardiovascular disease (CVD) and tumo (...truncated)


This is a preview of a remote PDF: https://ccforum.biomedcentral.com/track/pdf/10.1186/s13054-017-1821-z?site=ccforum.biomedcentral.com

Chen-Fei Zheng, Wen-Yue Liu, Fang-Fang Zeng, Ming-Hua Zheng, Hong-Ying Shi, Ying Zhou, Jing-Ye Pan. Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury, Critical Care, 2017, pp. 238, DOI: 10.1186/s13054-017-1821-z